Added to YB: 2022-09-07
Pitch date: 2022-09-07
TSVT [bullish]
2seventy bio, Inc.
-65.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.
Market Cap
$266.1M
Pitch Price
$14.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.20
P/E
-63.66
EV/Sales
6.88
Sector
Biotechnology
Category
N/A
Show full summary:
2SEVENTY BIO INC TSVT
A summary for this pitch has not been created yet.
Read full article (0 min)